isoxazoles has been researched along with Granulomatosis, Wegener's in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henes, JC; Kanz, L; Koetter, I | 1 |
| Reinhold-Keller, E | 1 |
| Fink, C; Gross, WL; Lamprecht, P; Metzler, C; Reinhold-Keller, E | 1 |
| Gross, WL; Hellmich, B; Lamprecht, P | 1 |
| Jayne, D | 1 |
| Fritz, J; Henes, JC; Horger, M; Kanz, L; Klein, R; Koch, S; Koetter, I; Risler, T | 1 |
| de Groot, K; Gross, WL; Hellmich, B; Iking-Konert, C; Manger, K; Metzler, C; Miehle, N; Reinhold-Keller, E | 1 |
1 review(s) available for isoxazoles and Granulomatosis, Wegener's
| Article | Year |
|---|---|
Advances in the therapy of Wegener's granulomatosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Etanercept; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Receptors, Tumor Necrosis Factor; Recurrence; Rituximab | 2006 |
2 trial(s) available for isoxazoles and Granulomatosis, Wegener's
| Article | Year |
|---|---|
Maintenance of remission with leflunomide in Wegener's granulomatosis.
Topics: Adult; Aged; Antirheumatic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Prednisolone; Recurrence; Treatment Outcome | 2004 |
Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Topics: Administration, Oral; Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; C-Reactive Protein; Cyclophosphamide; Drug Administration Schedule; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Hemoptysis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukopenia; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Treatment Outcome | 2007 |
4 other study(ies) available for isoxazoles and Granulomatosis, Wegener's
| Article | Year |
|---|---|
Rituximab and leflunomide for Wegener's granulomatosis: a long-term follow-up.
Topics: Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Isoxazoles; Leflunomide; Remission Induction; Rituximab; Treatment Outcome | 2011 |
[How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
Topics: Adjuvants, Immunologic; Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Controlled Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prednisolone; Prognosis; Remission Induction; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
Leflunomide versus methotrexate in Wegener's granulomatosis.
Topics: Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Recurrence; Remission Induction | 2007 |
Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; B-Lymphocytes; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Middle Aged; Radiography, Thoracic; Recurrence; Retrospective Studies; Rituximab; Tomography, X-Ray Computed | 2007 |